0001213900-23-094101.txt : 20231207 0001213900-23-094101.hdr.sgml : 20231207 20231207170008 ACCESSION NUMBER: 0001213900-23-094101 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231207 DATE AS OF CHANGE: 20231207 EFFECTIVENESS DATE: 20231207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Heart Test Laboratories, Inc. CENTRAL INDEX KEY: 0001468492 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 261344466 STATE OF INCORPORATION: TX FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-499091 FILM NUMBER: 231473003 BUSINESS ADDRESS: STREET 1: 550 RESERVE ST, SUITE 360 CITY: SOUTHLAKE STATE: TX ZIP: 76092 BUSINESS PHONE: 682-237-7781 MAIL ADDRESS: STREET 1: 550 RESERVE ST, SUITE 360 CITY: SOUTHLAKE STATE: TX ZIP: 76092 D 1 primary_doc.xml X0708 D LIVE 0001468492 Heart Test Laboratories, Inc. 550 RESERVE STREET SUITE 360 SOUTHLAKE TX TEXAS 76092 (682) 237-7781 TEXAS None None Corporation true Andrew Simpson 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Executive Officer Director Andrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors. Mark Hilz 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Executive Officer Director Mark Hilz is the Chief Operating Officer, Secretary and Director. Danielle Watson 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Executive Officer Danielle Watson is the Chief Financial Officer and Treasurer. Bruce Bent 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Director David R. Wells 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Director Brian Szymczak 550 Reserve Street Suite 360 Southlake TX TEXAS 76092 Director Other Health Care $1 - $1,000,000 06b false 2023-11-16 false true true false 0 934997 934997 0 Represents issuance of 4,854,853 shares of common stock, 710,605 pre-funded warrants and 914,148 warrants, in consideration of the right to commercialize a series of licenses, based on a closing price of $0.16 per share as of such issuance. false 1 0 0 0 false Heart Test Laboratories, Inc. /s/ Andrew Simpson Andrew Simpson Chief Executive Officer 2023-12-07